NASOPHARYNGEAL CANCER .2.

[1] ARTHUR J, 1964, BRIT J RADIOL, V37, P727

[2] OSTEONECROSIS IN PATIENTS TREATED WITH DEFINITIVE RADIOTHERAPY FOR SQUAMOUS-CELL CARCINOMAS OF ORAL CAVITY AND NASOPHARYNX AND OROPHARYNX [J]. RADIOLOGY, 1976, 119 (03) : 665 - 667

[3] Fletcher GH, 1973, TXB RADIOTHERAPY

[4] HSIEH T, 1971, NOV P SEC AS OC C OT, P500

[5] HUANG SC, 1980, INT J RADIAT ONCOL, V6, P401

[6] LEDERMAN M, 1961, CANCER NASOPHARYNX I

[7] RUBIN P, 1968, CLINICAL RADIATION P, V2, P557

[8] TAN B C, 1969, Clinical Radiology, V20, P329, DOI 10.1016/S0009-9260(69)80151-0

[9] Tan B C, 1966, Clin Radiol, V17, P302, DOI 10.1016/S0009-9260(66)80043-0

[1] ARTHUR J, 1964, BRIT J RADIOL, V37, P727

[2] OSTEONECROSIS IN PATIENTS TREATED WITH DEFINITIVE RADIOTHERAPY FOR SQUAMOUS-CELL CARCINOMAS OF ORAL CAVITY AND NASOPHARYNX AND OROPHARYNX [J]. RADIOLOGY, 1976, 119 (03) : 665 - 667

[3] Fletcher GH, 1973, TXB RADIOTHERAPY

[4] HSIEH T, 1971, NOV P SEC AS OC C OT, P500

[5] HUANG SC, 1980, INT J RADIAT ONCOL, V6, P401

[6] LEDERMAN M, 1961, CANCER NASOPHARYNX I

[7] RUBIN P, 1968, CLINICAL RADIATION P, V2, P557

[8] TAN B C, 1969, Clinical Radiology, V20, P329, DOI 10.1016/S0009-9260(69)80151-0

[9] Tan B C, 1966, Clin Radiol, V17, P302, DOI 10.1016/S0009-9260(66)80043-0